Latest Breaking News On - Pharmacogenomic testing - Page 7 : comparemela.com

According to latest report “Genetic Testing Market by Test Type (Predictive Testing, Carrier Testing, Prenatal and Newborn Testing, Diagnostic Testing, Pharmacogenomic Testing, Nutrigenomic Testing), Application (Cancer, Genetic Disease, Cardiovascular Disease), Regional Outlook, Price Trends, Competitive Market Share & Forecast 2027”, by Global Market Insights Inc., the market valuation of genetic testing will cross $31.8 billion by 2027. Availability of different genetic tests across the globe for early and accurate disease diagnosis will enhance the market growth during the forecast timeline. Direct-to-consumer genetic tests provides access to genetic information of the customers without necessarily involving any health insurance company or a healthcare provider in the process. DTC tests enable customers to identify a genetic predisposition to various diseases such as diabetes, cancer and Alzheimer’s. In addition, some DTC genetic tests are used for prediction of potent

United statesUnited kingdomAsia pacificGlobal market insights incHelix coCepheid danaher corporationBiocartis groupAbbott laboratoriesMe inc ltdTesting marketTest typePredictive testingCarrier testingNewborn testingDiagnostic testingPharmacogenomic testing